PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 30, 2026Journal of Clinical Oncology0 citations

Comparative Survival and Toxicity Outcomes in Lung Cancer Radiotherapy

Proton or photon? Comparative survival and toxicity outcomes in lung cancer radiotherapy: A systematic review and meta-analysis.

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRoshan Mustafa PathanJSJugraj SinghNTNabiha Tabassum

Discussion

Loading...

Member takes

Overview

Systematic review compares proton and photon radiotherapy outcomes in lung cancer, suggesting targeted use of protons.

Key Points

  • To compare survival and toxicity outcomes between proton and photon radiotherapy in non-small cell lung cancer.
  • Systematic search of Pubmed, MEDLINE, and Embase for observational studies comparing proton and photon RT.
  • Random-effects meta-analysis to pool risk and hazard ratios for toxicity and overall survival outcomes.
  • Included a total of 7 observational studies with 246,267 individuals.
  • Pooled analysis shows proton RT demonstrated a non-significant trend favoring overall survival (HR 0.79, 95% CI 0.51-1.23; P=0.29).
  • No significant overall survival benefit observed for Stage I NSCLC treated with SBRT (HR 0.70, 95% CI 0.32-1.55; P=0.38).
  • Proton RT showed significantly less toxicity in centrally located early-stage NSCLC (RR 0.32, 95% CI 0.14-0.74; P=0.008).

Cite This Study

Pathan et al. (2026) studied this question.

synapsesocial.com/papers/6a1a81100307b78509432e86https://doi.org/10.1200/jco.2026.44.16_suppl.e20048
View Full Paper
Ask AI
Bookmark
Share